Evidence map›Paper›PMID 31507416›Full record

ArticleFrontiers in pharmacology2019

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Jurgen Sota, Donato Rigante, Piero Ruscitti, Antonella Insalaco, Paolo Sfriso, Salvatore de Vita, Rolando Cimaz, Giuseppe Lopalco, Giacomo Emmi, Francesco La Torre and 23 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Off-label use of anti-IL-1 drugs in rheumatic diseases.International journal of immunopathology and pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 19 institutions in 1 country.

Jurgen SotaResearch Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Donato RiganteInstitute of Pediatrics, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.
Piero RuscittiDivision of Rheumatology, Department of Biotechnological and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy.
Antonella InsalacoDivision of Rheumatology, Department of Pediatric Medicine, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Paolo SfrisoRheumatology Unit, Department of Medicine, University of Padua, Padua, Italy.
Salvatore de VitaDepartment of Medical and Biological Sciences, Rheumatology Clinic, University of Udine, Udine, Italy.
Rolando CimazRheumatology Unit, Meyer Children's Hospital, University of Florence, Florence, Italy.
Giuseppe LopalcoDepartment of Emergency and Organ Transplantation-Rheumatology Unit, University of Bari, Bari, Italy.
Giacomo EmmiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Francesco La TorrePediatric Rheumatology Section, Pediatric Unit, Giovanni XXIII - Pediatric Hospital, Bari, Italy.
Claudia FabianiOphthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Alma Nunzia OlivieriDipartimento della donna del bambino e di chirurgia generale e specialistica, Università della Campania Luigi Vanvitelli, Italy.
Marco CattaliniPediatric Clinic, University of Brescia and Spedali Civili di Brescia, Brescia, Italy.
Daniele CammelliExperimental and Clinical Medicine Department, University of Florence, Florence, Italy.
Romina GallizziDepartment of Pediatrics, Azienda G. Martino, University of Messina, Messina, Italy.
Maria AlessioDepartment of Pediatrics, University Federico II, Naples, Italy.
Raffaele MannaPeriodic Fever Research Center, Università Cattolica Sacro Cuore, Rome, Italy.
Ombretta ViapianaRheumatology Section, Department of Medicine, University of Verona, Verona, Italy.
Micol FrassiRheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, University of Brescia and Spedali Civili di Brescia, Brescia, Italy.
Manuela PardeoDivision of Rheumatology, Department of Pediatric Medicine, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Armin MaierStruttura Semplice di Reumatologia, Ospedale di Bolzano, Bolzano, Italy.
Carlo SalvaraniRheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN IRCCS, Reggio Emilia, Italy.
Rosaria TalaricoRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Marta MoscaRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Serena ColafrancescoDepartment of Internal Medicine and Medical Specialties, Rheumatology Unit, Sapienza University of Rome, Rome, Italy.
Roberta PrioriDepartment of Internal Medicine and Medical Specialties, Rheumatology Unit, Sapienza University of Rome, Rome, Italy.
Maria Cristina MaggioUniversitary Department "Pro.S.A.M.I.", University of Palermo, Palermo, Italy.
Carla GaggianoClinical Pediatrics, Department of Molecular Medicine and Development, University of Siena, Siena, Italy.
Salvatore GrossoClinical Pediatrics, Department of Molecular Medicine and Development, University of Siena, Siena, Italy.
Fabrizio De BenedettiDivision of Rheumatology, Department of Pediatric Medicine, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Antonio VitaleResearch Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Roberto GiacomelliDivision of Rheumatology, Department of Biotechnological and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy.
Luca CantariniResearch Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
University of Siena · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITSapienza University of Rome · ITUniversity of Florence · ITUniversity of L'Aquila · ITUniversity of Pisa · ITFederico II University Hospital · ITMeyer Children's Hospital · ITOspedale di Bolzano · ITOspedale Pediatrico Giovanni XXIII · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Bari Aldo Moro · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Messina · ITUniversity of Padua · ITUniversity of Palermo · ITUniversity of Udine · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adult onset Still diseaseanakinradrug retention rateinnovative biotechnologiesinterleukin 1-betapersonalized medicinesystemic juvenile idiopathic arthritis

Identifiers

PMID31507416
PMCPMC6715768
OpenAlexW2947190733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.